ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...106107108109110111112113114115116...129130»
  • ||||||||||  moxidectin / Generic mfg., ivermectin / Generic mfg.
    Journal:  Impact on beef cattle productivity of infection with anthelmintic-resistant nematodes. (Pubmed Central) -  Nov 19, 2020   
    In calves naturally infected with resistant nematodes, under the production system assessed here, weight gains were lower in calves treated with anthelmintics that were moderately or highly ineffective compared to those treated with highly effective anthelmintics. These results demonstrate to farmers and veterinarians the importance of a sustainable and effective nematode control under field conditions.
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  Oral migration of Dirofilaria repens after creeping dermatitis. (Pubmed Central) -  Nov 18, 2020   
    Ivermectin treatment was given prior to diagnosis, while taking into consideration the most common causes of creeping dermatitis, but treatment was ineffective. The oral form of dirofilariasis is uncommon and could lead to diagnostic wandering.
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  Elimination of Simulium neavei-Transmitted Onchocerciasis in Wambabya-Rwamarongo Focus of Western Uganda. (Pubmed Central) -  Nov 18, 2020   
    The approach for elimination was twice yearly treatment with ivermectin for every round, treating at least 90% of all the eligible population...In 2017, after the PTS period, all 3,079 young children examined were negative for OV16 (95% CI: 0-0.16). Therefore, entomological and serological results provided evidence that resulted in the reclassification of Wambabya-Rwamarongo focus from "transmission interrupted" to "transmission eliminated" with no possibility of recrudescence.
  • ||||||||||  moxidectin / Generic mfg., ivermectin / Generic mfg.
    Retrospective data, Journal:  Implications of Endectocide Residues on the Survival of Aphodiine Dung Beetles: A Meta-Analysis. (Pubmed Central) -  Nov 12, 2020   
    It is often difficult to compare studies examining the effects of endectocides on dung fauna because of different experimental approaches, for example, active ingredients (eprinomectin, doramectin, ivermectin, moxidectin) and formulations (injectable, pour-on, spiked). Environ Toxicol Chem 2020;00:1-10.
  • ||||||||||  moxidectin / Generic mfg.
    Trial completion date, Trial primary completion date:  Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis (clinicaltrials.gov) -  Nov 10, 2020   
    P3,  N=1000, Not yet recruiting, 
    The results of this study suggest that CDDs, who are present in about 200,000 communities in 31 Sub Saharan African countries where onchocerciasis is endemic, can be successfully used to assess epilepsy prevalence, and therefore map epilepsy in many African countries. Trial completion date: Nov 2023 --> Jul 2024 | Trial primary completion date: Nov 2023 --> Jul 2022
  • ||||||||||  Journal:  Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating. (Pubmed Central) -  Nov 6, 2020   
    Lithocholic acid allosterically modulates P2X2 and P2X4 receptor sensitivity to ATP, reduces the rate of P2X4 receptor desensitization and antagonizes the effect of ivermectin on P2X4 receptor deactivation...Lithocholic acid also inhibits ATP-evoked currents in pituitary gonadotrophs expressing native P2 × 2, and potentiates ATP currents in nonidentified pituitary cells expressing P2 × 4 receptors. These results indicate that lithocholic acid is a bioactive steroid that may help to further unveil the importance of the P2 × 2, and P2 × 4 receptors in many physiological processes.
  • ||||||||||  chloroquine phosphate / Generic mfg., dexamethasone / Generic mfg., ivermectin / Generic mfg.
    Preclinical, Journal:  What to expect from different drugs used in the treatment of COVID-19: A study on applications and in vivo and in vitro results. (Pubmed Central) -  Nov 6, 2020   
    Several clinical studies are being performed to test possible drugs in response to the COVID-19 outbreak; however, there is still no treatment that is completely effective. Our goal in this paper is to bring together the results of main studies carried out with different drugs in order to help spread the knowledge about possible treatments for COVID-19 that have been suggested so far.
  • ||||||||||  metformin / Generic mfg., ivermectin oral / Generic mfg., fluvoxamine / Generic mfg.
    Enrollment change:  COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) (clinicaltrials.gov) -  Nov 2, 2020   
    P2/3,  N=70, Not yet recruiting, 
    Trial registration: The study was registered at ClinicalTrial.gov under the number NTC02032043. N=1522 --> 70